Abstract
Fifty-six patients in Europe were entered into a multi-centre study to compare the accuracy of technetium 99m methoxyisobutylisonitrile (99mTc-MIBI) for the detection of coronary artery disease (CAD) with thallium 201 (201T1) chloride perfusion scanning. The results showed a high degree of concordance between the two radiopharmaceuticals. Some 81% (678/840) of myocardial segments showed the same result (normal, infarct or ischaemia), and 80% (45/56) of patients had the same diagnosis. Overall detection of CAD in patients was 98% for201T1 and 96% for99mTc-MIBI. Detection of CAD in total arteries was 68% for both agents. In this study99mTc-MIBI was as accurate as201T1 for the detection of coronary artery stenoses.
| Original language | English |
|---|---|
| Pages (from-to) | 869-872 |
| Number of pages | 4 |
| Journal | European Journal of Nuclear Medicine |
| Volume | 16 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Dec 1990 |
| Externally published | Yes |
Keywords
- Coronary heart disease
- Multi-centre comparison
- Myocardial imaging
- Technetium 99m methoxyisobutylisonitrile
- Thallium 201
Fingerprint
Dive into the research topics of 'European multi-centre comparison of thallium 201 and technetium 99m methoxyisobutylisonitrile in ischaemic heart disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver